Unveiling Unexpected Immune Activities Induced by Your Pneumococcal Vaccine

by Julia L. Hurwitz, Elaine Tuomanen
Published 2016-03-01

Opening the OPK Assay Gatekeeper: Harnessing Multi-Modal Protection by Pneumococcal Vaccines

by Ashleigh N. Riegler, Beth Mann, Carlos J. Orihuela, Elaine Tuomanen
Published 2019-10-01

Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung.

by Kim S LeMessurier, Hans Häcker, Liying Chi, Elaine Tuomanen, Vanessa Redecke
Published 2013-01-01

Cephalosporin-resistant Pneumococci and Sickle Cell Disease

by Martha L. Miller, Caroline A. Obert, Geli Gao, Najat C. Daw, Patricia Flynn, Elaine Tuomanen
Published 2005-08-01

Noninvasive Monitoring of Pneumococcal Meningitis and Evaluation of Treatment Efficacy in an Experimental Mouse Model

by Jagath L. Kadurugamuwa, Kshitij Modi, Jun Yu, Kevin P. Francis, Carlos Orihuela, Elaine Tuomanen, Anthony F. Purchio, Pamela R. Contag
Published 2005-04-01

A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice

by Erik A. Karlsson, Victoria A. Meliopoulos, Nicholas C. van de Velde, Lee-Ann van de Velde, Beth Mann, Geli Gao, Jason Rosch, Elaine Tuomanen, Jon McCullers, Peter Vogel, Stacey Schultz-Cherry, Terence S. Dermody
Published 2017-09-01